跳至主要内容
临床试验/NCT03869645
NCT03869645终止不适用

CAPERE Thrombectomy System Post-Market Clinical Follow Up Study

Medtronic Endovascular3 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2019年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
18
试验地点
3
主要终点
Restoration of blood flow

研究概览

简要总结

A prospective, single-arm, non-blinded study, intending to collect and evaluate data in up to forty (40) human subjects with acute thrombosis, treated with the CAPERE™ Thrombectomy System.

详细描述

A prospective, single-arm, non-blinded study, intending to collect and evaluate data in up to forty (40) human subjects with acute thrombosis, treated with the CAPERE™ Thrombectomy System.

Subjects will be evaluated based on VEINES QoL survey pre- and post-treatment (30-days).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are greater than or equal to 18 years of age
  • Patients with clinical signs, symptoms and presentation consistent with acute thrombosis; onset of symptoms < 14 days
  • Patients cleared medically for invasive endovenous procedures

排除标准

  • Patients with IVC filter in area to be treated
  • Patients who are < 18 years of age.
  • Known anaphylactic reaction of radiographic contrast agents that cannot be pre- treated
  • Imaging evidence or other evidence that suggests the participant is not appropriate for mechanical thrombectomy intervention
  • Female who is pregnant or nursing
  • Concurrent participation in another investigational drug or device treatment study

结局指标

主要结局

Restoration of blood flow

时间窗: Day 0 - Intervention

Clearance of clot and restoration of venous flow of the affected vessel as confirmed using venogram immediately post-procedure

次要结局

  • Device Success(Day 0)
  • Technical Success Rate(Day 0)
  • Thrombus removal rate(Day 0)
  • Safety Endpoint(30 days)
  • VEINES Survey(</= Day 0 and Day 30)

研究者

发起方
Medtronic Endovascular
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验